Post-stroke depression: An update;Depresión post ictus: Una actualización

Neurologia

Volumn 30, Issue 1, 2015, Pages 23-31

  Esparrago Llorca G ^a   Castilla Guerra, L ^a   Fernandez Moreno M C ^b   Ruiz Doblado, S ^a   Jimenez Hernandez M D ^c  

^a HOSPITAL DE LA MERCED   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antidepressants; Cerebrovascular disease; Post stroke depression; Selective serotonin reuptake inhibitors; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

CEREBROVASCULAR ACCIDENT; COGNITION; DEPRESSION; HUMAN; MOTOR PERFORMANCE; PATHOGENESIS; PATIENT HEALTH QUESTIONNAIRE 2; PSYCHOSOCIAL WITHDRAWAL; SHORT SURVEY; SLEEP DISORDER; STROKE PATIENT; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; STROKE; SURVEYS AND QUESTIONNAIRES;

EID: 84921828469     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2012.06.008     Document Type: Short Survey

References (65)

1. Carod-Artal F.J. Depresión postictus (i). Epidemiología, criterios diagnósticos y factores de riesgo. Rev Neurol 2006, 42:169-175.
2. Dafer R.M., Rao M., Shareef A., Sharma A. Poststroke depression. Top Stroke Rehabil 2008, 15:13-21.
3. Angelelli P., Paolucci S., Bivona U., Piccardi L., Ciurli P., Cantagallo A., et al. Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study. Acta Psychiatr Scand 2004, 110:55-63.
4. Pohjasvaara T., Vataja R., Leppavuori A., Kaste M., Erkinjuntti T. Depression is an independent predictor of por long-term functional outcome poststroke. Eur J Neurol 2001, 8:315-319.
5. Lökk J., Delbari A. Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat 2010, 6:539-549.
6. Robinson R.G., Spalletta G. Poststroke depression: a review. Can J Psychiatry 2010, 55:341-349.
7. Chau J.P., Thompson D.R., Chang A.M., Woo J., Twinn S., Cheng S.K., et al. Depression among Chinese stroke survivors six months after discharge from a rehabilitation hospital. J Clin Nurs 2010, 19:3042-3050.
8. White C.L., McClure L.A., Wallace P.M., Braimah J., Liskay A., Roldan A., et al. The correlates and course of depression in patients with lacunar stroke: results from the Secondary Prevention of Small Subcortical Strokes (SPS3) study. Cerebrovasc Dis 2011, 32:354-360.
9. Spalletta G., Bria P., Caltagirone C. Sensitivity of somatic symptoms in post-stroke depression (PSD). Int J Geriatr Psychiatry 2005, 20:1103-1104.
10. Strober L.B., Arnett P.A. Assessment of depression in three medically ill, elderly populations: Alzheimer's disease, Parkinson's disease, and stroke. Clin Neuropsychol 2009, 23:205-230.
11. Johnson G., Burvill P., Anderson C., Jamrozik K., Stewart-Wynne E., Chakera T. Screening instruments for depression and anxiety following stroke: experience in the Perth community stroke study. Acta Psychiatr Scand 2007, 91:252-257.
12. Carod-Artal F., Ferreira Coral L., Trizotto D., Menezes Moreira C. Poststroke depression: prevalence and determinants in Brazilian stroke patients. Cerebrovasc Dis 2009, 28:157-165.
13. Quaranta D., Marra C., Gainotti G. Mood disorders after stroke: diagnostic validation of the poststroke depression rating scale. Cerebrovasc Dis 2008, 26:237-243.
14. Healey A., Kneebone I., Carroll M., Anderson S. A preliminary investigation of the reliability and validity of the Brief Assessment Schedule Depression Cards and the Beck Depression Inventory-Fast Screen to screen for depression in older stroke survivors. Int J Geriatr Psychiatry 2008, 23:531-536.
15. Berg A., Lönngvist J., Palomäki H., Kaste M. Assessment of depression after stroke: a comparison of different screening instruments. Stroke 2009, 40:523-529.
16. Rabi-Zikić T., Nedić A., Zarkob M., Slankamenac P., Dobrenov D., Zivanović Z. Poststroke depression: diagnosis of depression, phenomenology and specificity of depressive symptoms. Med Pregl 2009, 62:148-152.
17. De Man-van Ginkel J.M., Hafsteinsdòttir T., Lindeman E., Burger H., Grobbee D., Schuurmans M. An efficient way to detect poststroke depression by subsequent administration of a 9-item and a 2-item patient health questionnaire. Stroke 2012, 43:854-856.
18. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Press, Washington DC. 4th ed.
19. Robinson R.G., Kubos K.L., Starr L.B., Price T.R. Mood changes in stroke patients: relation to lesion location. Brain 1984, 107:81-93.
20. Starkstein S.E., Robinson R.G., Price T.R. Comparison of cortical and subcortical lesions in the production of post-stroke mood disorders. Brain 1987, 110:1045-1059.
21. Herrmann N., Black S.E., Lawrence J., Szekely C., Szalai J.P. The sunnybrook stroke study. A prospective study of depressive symptoms and functional outcome. Stroke 1998, 29:618-624.
22. Carson A.J., MacHale S., Allen K., Lawrie S.M., Dennis M., House A., et al. Depression after stroke and lesion location: a systematic review. Lancet 2000, 356:122-126.
23. Singh A., Black S.E., Herrmann N., Leibovitch F.S., Ebert P.L., Lawrence J., et al. Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke study. Stroke 2003, 31:637-644.
24. Bhogal S.K., Teasell R., Foley N., Speechley M. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke 2004, 35:794-802.
25. Nishiyama Y., Komaba Y., Ueda M., Nagayama H., Amemiya S., Katayama Y. Early depressive symptoms after ischemic stroke are associated with a left lenticulocapsular area lesion. J Stroke Cerebrovasc Dis 2010, 19:184-189.
26. Sachdev P.S., Chen X., Joscelyne A., Wen W., Brodaty H. Amygdala in stroke/transient ischemic attack patients and its relationship to cognitive impairment and psychopathology: the Sydney Stroke Study. Am J Geriatr Psychiatry 2007, 15:487-496.
27. Carod-Artal F.J. Depresión postictus (ii). Diagnóstico diferencial, complicaciones y tratamiento. Rev Neurol 2006, 42:238-244.
28. De Groot J.C., de Leeuw F.E., Oudkerk M., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000, 57:1071-1076.
29. Brodaty H., Withall A., Altendorf A., Sachdev P.S. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study. Am J Geriatr Psychiatry 2007, 15:477-486.
30. Chen Y., Chen X., Mok V.C., Lam W.W., Wong K.S., Tang W.K. Poststroke depression in patients with small subcortical infarcts. Clin Neurol Neurosurg 2009, 111:256-260.
31. Santos M., Gold G., Kövari E., Herrmann F.R., Bozikas V.P., Bouras C., et al. Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke 2009, 40:3557-3562.
32. Tang W.K., Chen Y.K., Lu J.Y., Chun W.C., Mok V.C., Ungvari G.S., et al. Cerebral microbleeds and depression in lacunar stroke. Stroke 2011, 42:2443-2446.
33. Dieguez S., Staub F., Bruggimann L., Bogousslavsky J. Is poststroke depression a vascular depression?. J Neurol Sci 2004, 226:53-58.
34. Glodzik-Sobanska L., Slowik A., McHugh P., Sobiecka B., Kozub J., Rich K.E., et al. Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Res 2006, 148:111-120.
35. Mitchell A.J. Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: a critical literature review. J Stroke Cerebrovasc Dis 1997, 6:377-388.
36. Spalletta G., Bossù P., Ciaramella A., Bria P., Caltagirone C., Robinson R.G. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006, 11:984-991.
37. Bossù P., Salani F., Cacciari C., Picchetto L., Cao M., Bizzoni F., et al. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res 2009, 6:163-170.
38. Pascoe M.C., Crewther S.G., Carey L.M., Crewther D.P. Inflammation and depression: why poststroke depression may be the norm and not the exception. Int J Stroke 2011, 6:128-135.
39. Su J.A., Chou S.Y., Tsai C.S., Hung T.H. Cytokine changes in the pathophysiology of poststroke depression. Gen Hosp Psychiatry 2011, 34:35-39.
40. Jiménez I., Sobrino T., Rodríguez-Yáñez M., Pouso M., Cristobo I., Sabucedo M., et al. High serum levels of leptin are associated with post-stroke depression. Psychol Med 2009, 39:1201-1209.
41. O'Brien S.M., Scott L.V., Dinan T.G. Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 2006, 188:449-452.
42. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008, 29:287-291.
43. Kohen R., Cain K.C., Mitchell P.H., Becker K., Buzaitis A., Millard S.P., et al. Association of serotonin transporter gene polymorphisms with post-stroke depression. Arch Gen Psychiatry 2008, 65:1296-1302.
44. Kim J.M., Stewart R., Kang H.J., Bae K.Y., Kim S.W., Shin I.S., et al. Associations of serotonergic genes with poststroke emotional incontinence. Int J Geriatr Psychiatry 2012, 27:799-806.
45. Fang J., Yan W., Jiang G.X., Li W., Cheng Q. Serotonin transporter gene polymorphism in Chinese patients with poststroke depression: a case-control study. Stroke 2011, 42:1461-1463.
46. Berg A., Palomäki H., Lehtihalmes M., Lönnqvist J., Kaste M. Post-stroke depression: an 18-month follow-up. Stroke 2003, 34:138-143.
47. Paradiso S., Vaidya J., Tranel D., Kosier T., Robinson R. Nondysphoric depression following stroke. J Neuropsychiatry Clin Neurosci 2008, 20:52-61.
48. Mast B. Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke. Am J Geriatr Psychiatry 2004, 12:315-322.
49. Churilov T.B., Skoog L., Blomstrand I., Linden C.T. Little evidence for different phenomenology in poststroke depression. Acta Psychiatr Scand 2010, 121:424-430.
50. Gusev E., Bogolepova A. Depressive disorders in stroke patients. Neurosci Behav Physiol 2009, 39:639-643.
51. Pohjasvaara T., Erkinjuntti T., Ylikoski R., Hietanen M., Vataja R., Kaste M. Clinical determinants of poststroke dementia. Stroke 1998, 29:75-81.
52. Lipsey J.R., Robinson R.G., Pearlson G.D., Rao K., Price T.R. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984, 1:297-300.
53. Andersen G., Vestergaard K., Lauritzen L.U. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994, 25:1099-1104.
54. Andersen G., Vestergaard K., Lauritzen L.U. Effective treatment of depression following apoplexy with citalopram. Ugeskr Laeger 1995, 157:2000-2003.
55. Wiart L., Petit H., Joseph P.A., Mazaux J.M., Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000, 31:1829-1832.
56. Robinson R.G., Schultz S.K., Castillo C., Kopel T., Kosier J.T., Newman R.M., et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000, 157:351-359.
57. Jorge R.E., Robinson R.G., Arndt S., Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003, 106:1823-1829.
58. Rampello L., Alvano A., Chiechio S., Raffaele R., Vecchio I., Malaguarnera M. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr 2005, 40:275-285.
59. Ried L.D., Jia H., Feng H., Cameon R., Wang X., Tueth M., et al. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality. Ann Pharmacother 2011, 45:888-897.
60. Mikami K., Jorge R.E., Moser D.J., Arndt S., Jang M., Solodkin A., et al. Increased frequency of first-episode poststroke depression after discontinuation of escitalopram. Stroke 2011, 42:3281-3283.
61. Jorge R.E., Acion L., Moser D., Adams H.P., Robinson R.G. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010, 67:187-196.
62. Choi-Kwon S., Choi J., Kwon S.U., Kang D.W., Kim J.S. Fluoxetine improves the quality of life in patients with poststroke emotional disturbances. Cerebrovasc Dis 2008, 26:266-271.
63. Cramer S.C. Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery. Int J Stroke 2011, 6:315-316.
64. Johnson M.L., Roberts M.D., Ross A.R., Witten C.M. Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil 1992, 71:239-241.
65. Tarango F.E., Allegri R., Vicario A., Bagnatti P., Lyketsos C.G. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of "vascular depression". Int J Geriatr Psychiatry 2001, 16:254-260.